1
Gautam Mitra: Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer. Miles Laboratories, Lester E Johnson, January 29, 1985: US04496689 (450 worldwide citation)

There is disclosed a process for producing a covalently attached alpha-1-proteinase inhibitor - water soluble polymer complex useful for pulmonary emphysema therapy, a covalently attached alpha-1-proteinase inhibitor - water soluble polymer complex produced by the process, a composition thereof in a ...


2
Mitra Gautam: Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer.. Miles Lab, July 10, 1985: EP0147761-A2 (7 worldwide citation)

There is disclosed a process for producing a covalently attached alpha-1-proteinase inhibitor - water soluble polymer complex useful for pulmonary emphysema therapy, a covalently attached alpha-1-proteinase inhibitor - water soluble polymer complex produced by the process, a composition thereof in a ...


3
Mitra Gautam: Complexe comprenant un inhibiteur de l.alpha.-1-proteinase et un polymere hydrosoluble reunis par des liens covalents, Covalently attached complex of .alpha.-1-proteinase inhibitor with a water soluble polymer. Miles, OGILVY RENAULT SENCRLSRL, October 4, 1988: CA1242664

ABSTRACT OF THE DISCLOSURE There is disclosed a process for producing a covalentlyattached alpha-1-proteinase inhibitor - water solublepolymer complex useful for pulmonary emphysema therapy, acovalently attached alpha-1-proteinase inhibitor - watersoluble polymer complex produced by the process, aco ...


4
RECOMBINANT HUMAN INTERFERON-LIKE PROTEINS. January 19, 2017: US20170015723-A1

This application relates to recombinant human interferon-like proteins. In one embodiment a recombinant protein created by gene shuffling technology in described having enhanced anti-viral and anti-proliferative activities in comparison to naturally occurring human interferon like alpha 2b (HuIFN-α2 ...


5
RECOMBINANT HUMAN INTERFERON-LIKE PROTEINS. March 14, 2019: US20190077843-A1

This application relates to recombinant human interferon-like proteins. In one embodiment a recombinant protein created by gene shuffling technology is described having enhanced anti-viral and anti-proliferative activities in comparison to naturally occurring human inteferon like alpha 2b (HuIFN-α2b ...